About Micro-Immunotherapy

Micro-immunotherapy is an innovative immunomodulation therapy that supports re-balancing of the immune response. Micro-immunotherapy therefore utilises low-dose, low-concentration immune messenger therapy support, in a specific sequence to optimise the re-balancing process. Health depends on immune homeostasis, and in turn immune homeostasis is a dynamic balance between two functions of the immune system:

Inflammation/Immune response
Tolerance/Regulation

Signalling molecules such as cytokines play a key role in maintaining this balance. Virtually all diseases are linked to imbalance of the immune system and either inflammation/immune response or tolerance/regulation:

Find Out More

Micro-immunotherapy seeks to support regulation of the immune system via the use of immunomodulatory substances in low doses. This mimics the body’s natural processes and supports tolerability of the therapy.

Key Features of Micro-Immunotherapy are:

Hormesis
Sequential signalling (which mimics the chain of immune response events)
Repetition (to enable the immune system to regain/sustain self-regulation)
Sub-lingual administration

Micro-Immunotherapy is a safe treatment, which can be combined with other therapeutic and treatment approaches. Nowadays, it is part of the therapeutic strategy of thousands of doctors, other health professionals and therapists in Europe and other parts of the world. Micro-immunotherapy is a key immunomodulatory option for daily practice.

Training in Micro-Immunotherapy:

For Training in

English: https://www.micro-immunotherapy.com/

Colab Services has on-demand Foundation and Advanced training in Micro-Immunotherapy and regularly hosts additional training and masterclasses. Please see our events page for further details.

Colabs also supports practitioners with MeGeMIT testing to support decision-making for a Micro-immunotherapy Protocols. See our Education Hub Immune System section for further information.

For French, German and Spanish language training in MIT please visit:

French: https://microimmuno.fr/

German: https://megemit.org/

Spanish: https://www.aemi.es/

Testing via Colab Services

Micro-Immunotherapy related testing via Colab Services Ltd includes the following Me-Ge-MIT tests

Our Test
LM6261 - Lymphocyte Typing (the test with the chart!)	View The Test
LM3539 - Helper Cell Typing (Th1/Th2/T-reg/Th17 status)	View The Test
LM4884 - Protein Profile (IgM,IgA,IgG, C3, a1-Antitrypsin, a1 glycoprotein, Haptoglobin, CRP, Transferrin, Albumin, Prealbuimin)	View The Test
LM4687 - Inflammation Profile (IL10, IFNy, IL5, IL23, IL8, TNFa, LBP, IL6)	View The Test
LM001 - Lymphocyte Typing (LM6261) plus partial viral panel (EBV, VZV, CMV, HSV1/2)	View The Test
LM002 - Lymphocyte Typing (LM6261) plus full viral panel EBV, VZV, CMV, HSV1/2, HHV6, RSV + Chlamydia pneumonia, psittaci, trachomatis)	View The Test

Q100 and Q150 are our bolt-on CIRS biomarkers for an evaluation of those patients with a suspected mould/environmental component to their cognitive decline.
NL864 is our bolt-on Lyme related Serology testing for evaluation of possible stealth infection.

View All Our Neurological/Cognitive tests

Scientific Updates

Latest published papers relating to MIT

About Micro-Immunotherapy

Key Features of Micro-Immunotherapy are:

Training in Micro-Immunotherapy:

Testing via Colab Services

Scientific Updates

Related Colab Education Videos on the Micro-Immunotherapy Protocol